MIRNEXT
Mirnext, a biomedical company, focuses on the discovery, validation, and commercialization of miRNAs as novel biomarkers for cardiovascular disease. Its multiple circulating miRNAs act as informative markers for the diagnosis of heart failure, coronary artery disease, and myocardial infarction, as well as used to predict cardiovascular risk, such as mortality and hospitalization. Mirnext also develops multi-marker tests to improve diagnostic routine and clinical management of patients entering the clinic with symptoms of heart failure or coronary artery disease. It has its headquarters in Amsterdam in the Netherlands.
MIRNEXT
Social Links:
Industry:
Biotechnology Genetics Health Care Lifestyle Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.mirnext.com
Total Employee:
1+
Status:
Active
Contact:
+31 (0) 20 69 71 087
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Domain Not Resolving AddThis
Current Employees Featured
Investors List
Limburg Ventures
Limburg Ventures investment in Venture Round - Mirnext
